Regulatory Spine Top Stories Amplio Spine Acquires and Commercializes KeyLift®, an FDA-Cleared Expandable Interlaminar Stabilization System Indicated for Supplemental Fusion of the Non-Cervical Spine byJosh SandbergJune 18, 2026
Biologics Spine Fziomed Initiates Commercialization of Oxiplex Gel in the United States byJosh SandbergNovember 5, 2025
Regulatory Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track byWill SandbergSeptember 26, 2025
Robotics Top Stories Robotic Commercialization and Operations Expert Chris Marrus Joins THINK Surgical byJosh SandbergJune 3, 2025
Recon Spine Top Stories Medtech Incubator Announces Partnership with BAAT Medical byJosh SandbergFebruary 11, 2025
Extremities The commercialization of Bioretec’s RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement byJosh SandbergNovember 20, 2024
Extremities Top Stories Commencing 2024 with Robust Growth through the Launch of Novel Foot and Ankle Products byJosh SandbergFebruary 27, 2024
Financial Spine Top Stories NanoHive Medical Secures a Venture Debt Round to Continue to Propel Commercialization byJosh SandbergDecember 11, 2023
Biologics Spine Top Stories Dr. Gail Naughton, world-renowned authority in the multibillion-dollar regenerative medicine market, joins HippoFi as the Head of Regenerative Therapeutics and Commercialization byJosh SandbergNovember 7, 2023
